Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 5,144 | 3,117 | 2,093 | 1,404 | 1,012 |
| Gross Profit | 5,144 | 3,117 | 2,093 | 1,404 | 1,012 |
| Operating Expenses | 59,092 | 55,451 | 60,676 | 59,663 | 48,722 |
| Operating Income | -53,948 | -52,334 | -58,583 | -58,259 | -47,710 |
| Other Income | 5,628 | 6,643 | 4,776 | 6,284 | 6,678 |
| Pre-tax Income | -48,320 | -45,691 | -53,807 | -51,975 | -41,032 |
| Income Tax | 32 | 67 | 176 | N/A | N/A |
| Net Income Continuous | -48,352 | -45,758 | -53,983 | -51,975 | -41,085 |
| Net Income | $-48,352 | $-45,758 | $-53,983 | $-51,975 | $-41,085 |
| EPS Basic Total Ops | -0.69 | -0.72 | -0.87 | -0.84 | -0.66 |
| EPS Basic Continuous Ops | -0.68 | -0.72 | -0.87 | -0.84 | -0.66 |
| EPS Diluted Total Ops | -0.69 | -0.72 | -0.87 | -0.84 | -0.66 |
| EPS Diluted Continuous Ops | -0.68 | -0.72 | -0.87 | -0.84 | -0.66 |
| EPS Diluted Before Non-Recurring Items | -0.69 | -0.72 | -0.87 | N/A | N/A |
| EBITDA(a) | $-55,769 | $-54,353 | $-60,942 | $-60,987 | $-48,926 |